SEI Investments SEIC continues to reward its shareholders through dividend hikes or additional share repurchases. The company recently announced its latest share-buyback plan, with authorization to repurchase common shares worth $250 million.Notably, the latest authorization inc
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
DocuSign, Inc. DOCU was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $68.68
Investors in First BanCorp. FBP need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2020 $9.00 Put had some of the highest implied volatility of all equity options today.
The oil industry is in jeopardy, thanks to the coronavirus pandemic that rattled most sectors until now. China's fuel demand is visibly crippled in the aftermath of large-scale travel bans imposed globally. To worsen matters, oil prices plummeted as Saudi Arabia waged a price wa
Accuray Incorporated ARAY has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at ARAY given that, according to its RSI reading of 21.49, it is now in o
Investors in Dave & Buster’s Entertainment, Inc. PLAY need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2020 $5.00 Put had some of the highest implied volatility of all equity options today.
Shutterstock, Inc. SSTK was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is down
The novel coronavirus (COVID-19) outbreak has been affecting stock prices worldwide for the past few weeks. After Mar 9, which has been termed as the ‘Black Monday’, investors have not seen any respite in the free fall of the benchmark indices in major markets. The Korea Com
The fear of the novel coronavirus is gripping the whole world and adversely impacting the global economy. The pandemic continues to spread, with the total count of infected people reaching 220,206, out of which 8,982 people have lost their lives. Amid this situation, Utilities a
Darden Restaurants (DRI) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of $1.88 per share. This compares to earnings of $1.80 per share a year ago. These figures are adjusted for non-recurring items.
The U.S. housing starts took a step back in February after surging for trailing four months, thanks to sharp decline in the construction of multifamily housing units. Building permits also tumbled from 13-year high numbers reported in January. Nonetheless, both the metrics came
AbbVie Inc. ABBV has been struggling lately, but the selling pressure may be coming to an end soon. That is because ABBV recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
AGNC Investment Corp. AGNC has been struggling lately, but the selling pressure may be coming to an end soon. That is because AGNC recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
Accenture (ACN) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.73 per share. This compares to earnings of $1.73 per share a year ago. These figures are adjusted for non-recurring items.
G-III Apparel Group (GIII) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.
Vascular Biogenics (VBLT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.